Our Work in Inflammation and Immunology
Additional Programs
- Biomarkers Consortium – Treatments Against RA and Effect on FDG PET-CT (TARGET Biomarker Study)
- Biomarkers Consortium – PROGRESS OA: Clinical Evaluation and Qualification of Osteoarthritis Biomarkers
- Biomarkers Consortium – Clinical Evaluation and Qualification of Translational Kidney Safety Biomarkers
- Biomarkers Consortium – Developing Endpoints for Clinical Trials in Community Acquired Bacterial Pneumonia (CABP) and Acute Skin and Skin Infections (ABSSSI)
- Biomarkers Consortium – Mucosal Healing in UC: Definition, Treatment Target and Clinical Endpoints
- Biomarkers Consortium – Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Clinical Endpoint Development (HABP/VABP)